KBLB Kraig Biocraft Laboratories Inc.

Kraig Biocraft Laboratories Hosts Online Press Conference Today

Kraig Biocraft Laboratories Hosts Online Press Conference Today

ANN ARBOR, Mich., April 16, 2020 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”), the leading developer of spider silk based fibers, announces the Company will an online press conference, today at 4:30 p.m. Eastern Time, to introduce a game changing Spider Silk technological breakthrough.  This conference will open to all press, stakeholders and interested parties, via a live streaming broadcast at .

The webcast will be accessible on most operating systems and browsers and a replay will be available, following the event, within the Investor Relations section of the Company's web site.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to .

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

EN
16/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kraig Biocraft Laboratories Inc.

 PRESS RELEASE

Kraig Biocraft Laboratories Successfully Completes March/April Product...

Kraig Biocraft Laboratories Successfully Completes March/April Production Cycle; May Production Now Underway Company Continues to Meet 2025 Scale-Up Targets ANN ARBOR, Mich., May 06, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that it has successfully completed its March/April spider silk production run and is currently well underway with its May production cycle. This steady progress reflects the Company's continued execution against its 2025 production scale-up plan,...

 PRESS RELEASE

Kraig Biocraft Laboratories Provides Production Update on Recombinant ...

Kraig Biocraft Laboratories Provides Production Update on Recombinant Spider Silk Operations ANN ARBOR, Mich., April 21, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a world leader in spider silk technology*, is pleased to provide an update on recombinant spider silk production. The Company continues to increase its production output and is now in the middle of its largest-ever batch of recombinant spider silk production. Kraig Labs can now report that it has successfully completed the first half of its current production batch...

 PRESS RELEASE

Kraig Biocraft Laboratories Announces the Launch of Advanced Gene-Spli...

Kraig Biocraft Laboratories Announces the Launch of Advanced Gene-Splicing Program and New Transgenics Company Adopting Advanced Gene Editing Platform Across All Commercial Silkworm Development Programs ANN ARBOR, Mich., April 15, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology1, today announced the successful rollout of a next-generation molecular biology and gene-splicing platform. This powerful new system represents a major leap forward in the Company's ability to create and refine genetica...

 PRESS RELEASE

Kraig Biocraft Laboratories is Happy to Announce its New Director of M...

Kraig Biocraft Laboratories is Happy to Announce its New Director of Molecular Biology as it Accelerates Advanced Fibers Development ANN ARBOR, Mich., April 07, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk-based super materials, is pleased to announce the appointment of Dr. Xiaoli Zhang as Director of Molecular Biology. Dr. Zhang is a proven research and development leader in the field of molecular biology and bioengineering, with numerous groundbreaking accomplishments in spider silk and transgenic ...

 PRESS RELEASE

Kraig Biocraft Laboratories Secures Four Registered Trademarks for Spy...

Kraig Biocraft Laboratories Secures Four Registered Trademarks for SpydaSilk® Brand, to Advance Commercialization Strategy for Recombinant Spider Silk ANN ARBOR, Mich., April 01, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or the "Company"), a world leader in recombinant spider silk technology, today announced that it has secured four registered trademarks for its SpydaSilk® brand. These trademarks represent a key milestone in the Company's strategy to commercialize its revolutionary spider silk technology and position SpydaSilk® as a premium app...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch